PTG-0861: A novel HDAC6-selective inhibitor as a therapeutic strategy in acute myeloid leukaemia

This publication has 38 references indexed in Scilit:

• Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
  Blood, 2012
• Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
  Current Opinion in Structural Biology, 2011
• Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A
  Journal of the American Chemical Society, 2010
• The many roles of histone deacetylases in development and physiology: implications for disease and therapy
  Nature Reviews Genetics, 2009
• Development of a fluorescence polarization based assay for histone deacetylase ligand discovery
  Bioorganic & Medicinal Chemistry Letters, 2008
• Histone Deacetylase 6 Regulates Growth Factor-Induced Actin Remodeling and Endocytosis
  Molecular and Cellular Biology, 2007
• Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
  International Journal of Cancer, 2007
• A Metabolic Screening Study of Trichostatin A (TSA) and TSA-Like Histone Deacetylase Inhibitors in Rat and Human Primary Hepatocyte Cultures
  The Journal of Pharmacology and Experimental Therapeutics, 2007
• Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication
  Molecular and Cellular Biology, 2005
• The history of cancer epigenetics
  Nature Reviews Cancer, 2004